Eye Diseases

237 trials 74 recruiting

Filter these 237 trials by phase, country and sponsor.

Open in Search →

Phase IIIb Study of 36-Week Refill Exchanges of Port Delivery System with Ranibizumab in nAMD Recruiting

2024-516924-32-00 Neovascular Age-Related Macular Degeneration (nAMD) 5 2025-10-17
A Phase I/IIa Clinical Trial to Assess the Safety, Tolerability, and Efficacy of a Single Intravitreal Injection of SPVN20 Gene Therapy in P… Recruiting

2025-520665-47-00 End-stage rod-cone dystrophy 1 2025-10-08
A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retiniti… Recruiting

2024-515199-10-01 Retinitis Pigmentosa 4 2025-09-29
A phase III, randomized, double blind, multiple doses, placebo-controlled parallel-group, adaptive study to evaluate the efficacy of atropin… Recruiting

2023-510439-13-00 Myopia 5 2025-09-25
A phase IV study of Faricimab to explore associations of visual acuity benefits and changes in vascular integrity using adaptive optics in p… Recruiting

2023-509829-52-00 Macular edema 6 2025-09-01
Comparing postoperative recovery after vitrectomy using NSAID eyedrops versus steroid eyedrops Recruiting

2024-518807-23-00 Macular hole 6 2025-09-01
EORTC 2022-MG: Treatment with tebentafusp or observation for patients with melanoma of the eye after surgery or radiation (ATOM Trial) Recruiting

2023-510333-28-00 Uveal Melanoma 5 2025-08-20
A phase IV, multicentre, open-label, single-arm study to investigate the efficacy, safety and durability of faricimab (RO6867461) in caucasi… Recruiting

2024-515640-22-00 polypoidal choroidal vasculopathy 6 2025-08-06
A Double-Masked, Randomized, Placebo-Controlled, Paired Eye Study to Evaluate the Efficacy, Safety and Tolerability of Sepofarsen in Subject… Recruiting

2024-518378-14-00 Leber congenital amaurosis (LCA) 5 2025-07-11
A Study to Determine Safety and Long-Term Effectiveness of Faricimab in Participants with Age-Related Macular Degeneration Recruiting

2024-517545-13-00 Neovascular Age-Related Macular Degeneration 11 2025-06-04
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
Ikervis in the Treatment of Atopic Keratoconjunctivitis - a Prospective, Randomized, Placebo-Controlled Trial Recruiting

2022-500633-92-00 Atopic Keratoconjunctivitis 4 2025-05-09
A clinical trial to evaluate the safety and the efficacy of NEXAGON ® (Lufepirsen Ophthalmic Gel) in subjects with Persistent Corneal Epithe… Recruiting

2023-507030-24-00 Persistent Corneal Epithelial Defects 4 2025-04-30
Additive Benefits of Semaglutide for open-AngLe glaucoma – an Opportunity for Neuroprotection (ABSALON) Recruiting

2024-518510-87-00 Glaucoma 6 2025-04-10
Study of an artificial human tissue medicament for patients with severe corneal ulcers that not respond to conventional therapies. Recruiting

2023-506856-25-00 Corneal ulcer 4 2025-03-12
Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 … Recruiting

2022-500747-21-00 Geographic Atrophy 4 2025-02-27
Phase II study of Roginolisib in UM patients Recruiting

2024-514333-37-00 Advanced Metastatic Ocular/Uveal Melanoma 4 2025-02-25
A trial in patients suffering from a specific form of an eye disorder called retinitis pigmentosa Recruiting

2023-504383-42-00 Retinitis Pigmentosa (due to CNGA1 mutation) 7 2025-02-02
Randomized clinical trial to evaluate the efficacy of fibrin membrane graft with eye drops concentrated in autologous growth factors in prim… Recruiting

2025-520640-15-00 pterygium 11 2025-01-30
Pred Forte® versus placebo eye drops in chronic central serous chorioretinopathy trial (PICS trial) Recruiting

2024-511575-15-00 Central serous chorioretinopathy 5 2025-01-29
Comparison of topical hydrocortisone versus dexamethasone treatment for inflammatory secretions of the conjunctiva in patients with ocular p… Recruiting

2024-517441-14-00 inflammatory secretions of the conjunctiva (Eye desease 11 2024-10-30
Effect of Treatment with Finerenone on Cardio-Renal Target Organ Damage in Patients with Type 2 Diabetes – A Randomized Trial Recruiting

2023-504446-58-00 Type 2 diabetes, chronic kidney disease 6 2024-10-15
IDE196 (Darovasertib) in Combination with Crizotinib as First-line Therapy in Metastatic Uveal Melanoma Recruiting

2023-506686-66-01 HLA-A2 negative metastatic uveal melanoma 10 2024-10-09
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Retinal Gene Therapy in Subjects with Choroideremia Previously Treated wi… Recruiting

2023-507994-16-00 Choroideremia (CHM) X-Linked Retinitis Pigmentosa (XLRP 5 2024-10-07